 |
| Tim Bird |
Tim Bird, former CEO of M Booth Health, Health Unlimited and Cooney Waters, has joined LifeSci Communications as executive VP, client services.
With more than 30 years of healthcare PR experience, Bird will help LifeSci clients navigate the complex commercial environment and support their products through the clinic and into the hands of prescribers.
Bird looks forward to “helping the LifeSci team champion innovation, shape health policies, and advance new medicines to fill unmet needs and create lasting change in health.”
Most recently, Bird was running Slope Drive Consulting. He exited the M Booth Health chairman post in July 2022.
He also did stints in the healthcare practices of Hill & Knowlton (senior VP) and Burson-Marsteller (managing director).
LifeSci, which is based in New York, has offices in Boston, London, Madrid and Geneva.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
